Trademark

OFEZUMIR Trademark Information

Number:
2353852
Ir number:
1728116
Words:
OFEZUMIR
Kind:
Word
Status group:
REGISTERED
Status code:
Protected
Status detail:
Registered/protected
Priority date:
03 Oct 2022
Lodgement date:
31 Mar 2023
Ir notification date:
04 May 2023
Ir renewal due date:
31 Mar 2033
First report date:
10 May 2023
Acceptance date:
10 May 2023
Acceptance advertised date:
10 May 2023
Entered on register date:
17 Jul 2023
Registered from date:
31 Mar 2023
Registration advertised date:
17 Jul 2023
Renewal due date:
31 Mar 2033
Filing date:
31 Mar 2023
Ir contact:
, , Makiko Coffland, , Array
Indexing constituents:
OFEZUMIR
Class:
5,16,44
Convention details:
Array
Mark categories:
Trademark
Registration date:
2023-07-17
Last status check:
2026-07-03 06:45:22
Goods and services:
1) Class: 5
Description: Pharmaceutical preparations for the treatment of cancer, pharmaceutical preparations for the treatment of immunological disorders, pharmaceutical preparations for the treatment of graft versus host disorder (GVHD), pharmaceutical preparations for the treatment of hematological disorders, pharmaceutical preparations for the treatment of hypophosphatemia disorders, pharmaceutical preparations for the treatment of myeloproliferative disorders, pharmaceutical preparations for the treatment of skeletal or chondrocyte disorders, pharmaceutical preparations for the treatment of dermatological disorders.
2) Class: 16
Description: Printed brochures, newsletters, and pamphlets in the fields of medical issues, procedures, disease symptoms, patient support and community building.
3) Class: 44
Description: Providing a medical information to healthcare providers and patients relating to viral, hematological, auto-immune, graft versus host, inflammatory, metabolic and dermatological disorders.
History and publication details:
1) Date: 2026-01-15
Display name: Amendment to International Registration Contact Requested
2) Date: 2023-07-18
Display name: International Registration in Australia Protected correspondence sent
3) Date: 2023-07-17
Display name: IP Right Registration Published
4) Date: 2023-07-17
Display name: Status change to Registered/Protected
5) Date: 2023-05-11
Display name: Application Accepted correspondence sent
6) Date: 2023-05-10
Display name: IP Right has been Examined
7) Date: 2023-05-10
Display name: IP Right Acceptance Published
8) Date: 2023-05-10
Display name: Status change to Accepted
9) Date: 2023-05-09
Display name: Awaiting examination
10) Date: 2023-05-09
Display name: Examination expedited
11) Date: 2023-05-04
Display name: IP Right Filed Published
12) Date: 2023-05-04
Display name: Status change to Published
13) Date: 2023-05-04
Display name: Status change to Filed
14) Date: 2023-05-04
Display name: IP right goods and service classes updated
Description: Class Count: 3 Class Numbers:5; 16; 44
Previous details: Class Count: 0 Class Numbers:
New details: Class Count: 3 Class Numbers: 5; 16; 44
15) Date: 2023-05-04
Display name: IP Right Goods and Services Items updated
Description: Class Number: 16
Previous details:
New details: Class Number: 16 Class Items: Printed brochures, newsletters, and pamphlets in the fields of medical issues, procedures, disease symptoms, patient support and community building.
16) Date: 2023-05-04
Display name: IP Right Goods and Services Items updated
Description: Class Number: 44
Previous details:
New details: Class Number: 44 Class Items: Providing a medical information to healthcare providers and patients relating to viral, hematological, auto-immune, graft versus host, inflammatory, metabolic and dermatological disorders.
17) Date: 2023-05-04
Display name: IP Right Goods and Services Items updated
Description: Class Number: 5
Previous details:
New details: Class Number: 5 Class Items: Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of immunological disorders; pharmaceutical preparations for the treatment of graft versus host disorder (GVHD); pharmaceutical preparations for the treatment of hematological disorders; pharmaceutical preparations for the treatment of hypophosphatemia disorders; pharmaceutical preparations for the treatment of myeloproliferative disorders; pharmaceutical preparations for the treatment of skeletal or chondrocyte disorders; pharmaceutical preparations for the treatment of dermatological disorders.
18) Date: 2023-05-04
Display name: Status change to Received
19) Date: 2023-05-04
Display name: Trade mark representation updated
20) Date: 2023-05-04
Display name: Application Received

Owner Information
Owner structured address:
1801 Augustine Cut-Off Wilmington DE 19803, UNITED STATES OF AMERICA

Owner is private:
0
Scroll to Top